Oral pill boosts fat burning by energizing muscle metabolism, sidestepping Ozempic drawbacks

An experimental oral β2 agonist pill activates metabolism in skeletal muscle to lower blood sugar and increase fat burning without reducing appetite or causing muscle loss, addressing downsides seen with GLP-1 drugs like Ozempic. Early Phase I results show good tolerability in healthy volunteers and people with type 2 diabetes, with Phase II trials planned to test efficacy and potential use alone or with existing therapies.